Based on the MeRIP‐seq results and the previously identified abnormal abundance of ZFP14 in ccRCC, experiments were conducted to confirm whether ZFP14 is a downstream target of METTL14‐dominated m6A, potentially responsible for its impaired expression. Here, METTL14 is linked to nonpapillary renal cell carcinoma.